NovoCure (NVCR) EBIT Margin Growth (3y) (2017 - 2026)
Powered by 
Analysis
NovoCure (NVCR) EBIT Margin Growth (3y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.63 Bn | 178.03 Bn | 7.27 Bn | -201.00 |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | 722.00 |
| 3 | Medtronic | 118.51 Bn | 109.69 Bn | 6.34 Bn | 162.00 |
| 4 | Stryker | 106.53 Bn | 103.06 Bn | 4.50 Bn | 586.00 |
| 5 | Boston Scientific | 66.52 Bn | 65.98 Bn | 3.85 Bn | 736.00 |
| 6 | Edwards Lifesciences | 49.57 Bn | 45.32 Bn | 1.35 Bn | 887.00 |
| 7 | Alcon | 34.00 Bn | 32.55 Bn | 1.68 Bn | -1,075.00 |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | 963.00 |
| 9 | Steris | 21.12 Bn | 20.64 Bn | 684.20 Mn | 244.00 |
| 10 | NovoCure | 1.90 Bn | 1.46 Bn | 142.48 Mn | 4,396.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,396.00 |
| Mar 31, 2026 | 1,058.00 |
| Dec 31, 2025 | 1,030.00 |
| Sep 30, 2025 | -276.00 |
| Jun 30, 2025 | -989.00 |
| Mar 31, 2025 | -2,384.00 |
| Dec 31, 2024 | -2,169.00 |
| Sep 30, 2024 | -1,429.00 |
| Jun 30, 2024 | -1,313.00 |
| Mar 31, 2024 | -2,991.00 |
| Dec 31, 2023 | -4,706.00 |
| Sep 30, 2023 | -5,707.00 |
| Jun 30, 2023 | -5,546.00 |
| Mar 31, 2023 | -4,599.00 |
| Dec 31, 2022 | -3,362.00 |
| Sep 30, 2022 | -2,297.00 |
| Jun 30, 2022 | -1,638.00 |
| Mar 31, 2022 | 776.00 |
| Dec 31, 2021 | -513.00 |
| Sep 30, 2021 | 170.00 |